MedTrace Logo

Health Literacy of Postpartum Women and Family Planing

NCT05800548 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2

Last updated 2023-04-05

No results posted yet for this study

Summary

This study was carried out as a cross-sectional-relationship searcher in order to determine the effect of evaluating the relationship between health literacy and family planning attitudes of postpartum women.

The population of the study consisted of puerperant women in the Postpartum Clinic of Osmaniye State Hospital between March 2022 and June 2022. The sample of the research is; puerperant women who applied to the hospital for delivery within the research dates and gave birth in a healthy way, did not have any risk for the mother and the baby, had no communication barriers and met the research criteria. The sample number of the study was calculated using the G\*Power 3.1.9.4 program.

The puerperant women who met the inclusion criteria were included in the study with the method of improbable random sampling, and a total of 258 puerperant women were reached.

In data collection; Socio-demographic and obstetric characteristics of puerperant women, descriptive information form including questions about current birth, Postpartum Family Planning Attitude Scale The Health Literacy Scale was used. In the study, a very strong positive correlation was found between the women's total PAPTS score and SAS total score (p=0.000). In other words; As the health literacy levels of postpartum women increase, their family planning attitude levels also increase

Conditions

  • Contraception
  • Health Attitude
  • Postpartum

Interventions

OTHER

survey application

In data collection; Socio-demographic and obstetric characteristics of puerperant women, descriptive information form including questions about current birth, Postpartum Family Planning Attitude Scale The Health Literacy Scale was used.

Sponsors & Collaborators

  • Mersin University

    collaborator OTHER

  • Osmaniye Korkut Ata University

    lead OTHER

Eligibility

Min Age
19 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2022-05-31
Completion
2022-08-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05800548 on ClinicalTrials.gov